76
Participants
Start Date
July 12, 2022
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Insulin + semaglutide treatment
Usual insulin treatment + semaglutide (0.25 mg/week for 4 weeks, then 0.50 mg/week for 4 weeks, then 1 mg/week for 18 weeks, i.e. a total duration of 26 weeks). Upon introduction of semaglutide (ozempic) treatment, insulin doses will be reduced by 10% (basal insulin, basal rate and bolus)
Usual insulin treatment
Usual insulin treatment
Biological check-up
at D0, D90 and D180
RECRUITING
Chu Dijon Bourgogne, Dijon
Centre Hospitalier Universitaire Dijon
OTHER